High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

Breast Cancer Research and Treatment

Volumn 129, Issue 3, 2011, Pages 747-760

  Johansson, Ida ^a   Nilsson, Cecilia ^b,c   Berglund, Pontus ^a   Strand, Carina ^a   Jönsson, Göran ^a   Staaf, Johan ^a   Ringnér, Markus ^a   Nevanlinna, Heli ^d   Barkardottir, Rosa B ^e   Borg, Åke ^a   Olsson, Håkan ^a   Luts, Lena ^a   Fjällskog, Marie Louise ^c   Hedenfalk, Ingrid ^a  

^a LUND UNIVERSITY   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Array CGH; BPH; BRCA2; Male breast cancer; Molecular subtypes

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BREAST CANCER; CHROMOSOME ABERRATION; CHROMOSOME ARM; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FEMALE BREAST CANCER; GENE AMPLIFICATION; GENETIC DIFFERENCE; GENETIC GAIN; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; PRIORITY JOURNAL; SEX DIFFERENCE; TISSUE MICROARRAY;

ADULT; AGED, 80 AND OVER; BRCA2 PROTEIN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION;

EID: 80052564919     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1262-8     Document Type: Article

References (54)

1. NORDCAN: Cancer incidence, mortality, prevalence and prediction in the nordic countries (2009) Association of the Nordic Cancer Registries. Danish Cancer Society. http://www.ancr.nu
2. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 4 225 249 10.3322/caac.20006 19474385 10.3322/caac.20006
3. A Stang C Thomssen 2008 Decline in breast cancer incidence in the United States: what about male breast cancer? Breast Cancer Res Treat 112 3 595 596 10.1007/s10549-007-9882-3 18176840 10.1007/s10549-007-9882-3
4. SH Giordano 2005 A review of the diagnosis and management of male breast cancer Oncologist 10 7 471 479 10.1634/theoncologist.10-7-471 16079314 10.1634/theoncologist.10-7-471 (Pubitemid 41266328)
5. A Agrawal AA Ayantunde R Rampaul JF Robertson 2007 Male breast cancer: a review of clinical management Breast Cancer Res Treat 103 1 11 21 10.1007/s10549-006-9356-z 17033919 10.1007/s10549-006-9356-z 1:STN:280:DC%2BD2s3ktFyhtg%3D%3D (Pubitemid 46653271)
6. LA Korde JA Zujewski L Kamin S Giordano S Domchek WF Anderson JM Bartlett K Gelmon Z Nahleh J Bergh B Cutuli G Pruneri W McCaskill-Stevens J Gralow G Hortobagyi F Cardoso 2010 Multidisciplinary meeting on male breast cancer: summary and research recommendations J Clin Oncol 28 12 2114 2122 10.1200/JCO.2009.25.5729 20308661 10.1200/JCO.2009.25.5729
7. V Ciocca A Bombonati Z Gatalica M Di Pasquale A Milos A Ruiz-Orrico D Dreher N Folch F Monzon G Santeusanio CM Perou PS Bernard JP Palazzo 2006 Cytokeratin profiles of male breast cancers Histopathology 49 4 365 370 10.1111/j.1365-2559.2006.02519.x 16978199 10.1111/j.1365-2559.2006.02519.x 1:STN:280:DC%2BD28rlsVSksw%3D%3D (Pubitemid 44401543)
8. C Rudlowski N Friedrichs A Faridi L Fuzesi R Moll G Bastert W Rath R Buttner 2004 Her-2/neu gene amplification and protein expression in primary male breast cancer Breast Cancer Res Treat 84 3 215 223 10.1023/B:BREA.0000019953. 92921.7e 15026619 10.1023/B:BREA.0000019953.92921.7e 1:CAS:528: DC%2BD2cXitFWrurw%3D (Pubitemid 38445371)
9. L Ottini P Rizzolo I Zanna M Falchetti G Masala K Ceccarelli V Vezzosi A Gulino G Giannini S Bianchi F Sera D Palli 2009 BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy Breast Cancer Res Treat 116 3 577 586 10.1007/s10549-008-0194-z 18819001 10.1007/s10549-008-0194-z
10. L Ottini D Palli S Rizzo M Federico V Bazan A Russo 2009 Male breast cancer Crit Rev Oncol Hematol 73 2 141 155 10.1016/j.critrevonc.2009.04.003 19427229 10.1016/j.critrevonc.2009.04.003
11. LA Brinton DA Richesson GL Gierach JV Lacey Jr Y Park AR Hollenbeck A Schatzkin 2008 Prospective evaluation of risk factors for male breast cancer J Natl Cancer Inst 100 20 1477 1481 10.1093/jnci/djn329 18840816 10.1093/jnci/djn329
12. KS Heller PP Rosen D Schottenfeld R Ashikari DW Kinne 1978 Male breast cancer: a clinicopathologic study of 97 cases Ann Surg 188 1 60 65 208472 10.1097/00000658-197807000-00010 1:STN:280:DyaE1c3gvFKjsQ%3D%3D (Pubitemid 8373178)
13. WF Anderson SS Devesa 2005 In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute Cancer 104 8 1733 1741 10.1002/cncr.21353 16138363 10.1002/cncr.21353 (Pubitemid 41437439)
14. L Thalib P Hall 2008 Survival of male breast cancer patients: Population-based cohort study Cancer Sci 100 2 292 295 10.1111/j.1349-7006.2008. 01032.x 10.1111/j.1349-7006.2008.01032.x
15. SH Giordano DS Cohen AU Buzdar G Perkins GN Hortobagyi 2004 Breast carcinoma in men: a population-based study Cancer 101 1 51 57 10.1002/cncr.20312 15221988 10.1002/cncr.20312 (Pubitemid 38812422)
16. WL Donegan PN Redlich PJ Lang MT Gall 1998 Carcinoma of the breast in males: a multiinstitutional survey Cancer 83 3 498 509 9690543 10.1002/(SICI)1097-0142(19980801)83:3<498::AID-CNCR19>3.0.CO;2-R 1:STN:280:DyaK1czlt1ymsQ%3D%3D (Pubitemid 28354506)
17. SH Giordano 2008 Male breast cancer: it's time for evidence instead of extrapolation Onkologie 31 10 505 506 10.1159/000153894 18854647 10.1159/000153894
18. G Jonsson J Staaf J Vallon-Christersson M Ringner K Holm C Hegardt H Gunnarsson R Fagerholm C Strand BA Agnarsson O Kilpivaara L Luts P Heikkila K Aittomaki C Blomqvist N Loman P Malmstrom H Olsson OT Johannsson A Arason H Nevanlinna RB Barkardottir A Borg 2010 Genomic subtypes of breast cancer identified by array comparative genomic hybridization display distinct molecular and clinical characteristics Breast Cancer Res 12 3 R42 10.1186/bcr2596 20576095 10.1186/bcr2596
19. K Chin S DeVries J Fridlyand PT Spellman R Roydasgupta WL Kuo A Lapuk RM Neve Z Qian T Ryder F Chen H Feiler T Tokuyasu C Kingsley S Dairkee Z Meng K Chew D Pinkel A Jain BM Ljung L Esserman DG Albertson FM Waldman JW Gray 2006 Genomic and transcriptional aberrations linked to breast cancer pathophysiologies Cancer Cell 10 6 529 541 10.1016/j.ccr.2006.10.009 17157792 10.1016/j.ccr.2006.10.009 1:CAS:528:DC%2BD28XhtlCnsrbF (Pubitemid 44854748)
20. Z Hu C Fan DS Oh JS Marron X He BF Qaqish C Livasy LA Carey E Reynolds L Dressler A Nobel J Parker MG Ewend LR Sawyer J Wu Y Liu R Nanda M Tretiakova A Ruiz Orrico D Dreher JP Palazzo L Perreard E Nelson M Mone H Hansen M Mullins JF Quackenbush MJ Ellis OI Olopade PS Bernard CM Perou 2006 The molecular portraits of breast tumors are conserved across microarray platforms BMC Genomics 7 96 10.1186/1471-2164-7-96 16643655 10.1186/1471-2164-7-96 (Pubitemid 43786485)
21. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel S Deng H Johnsen R Pesich S Geisler J Demeter CM Perou PE Lonning PO Brown AL Borresen-Dale D Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 14 8418 8423 10.1073/pnas.0932692100 12829800 10.1073/pnas.0932692100 1:CAS:528: DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
22. J Fridlyand AM Snijders B Ylstra H Li A Olshen R Segraves S Dairkee T Tokuyasu BM Ljung AN Jain J McLennan J Ziegler K Chin S Devries H Feiler JW Gray F Waldman D Pinkel DG Albertson 2006 Breast tumor copy number aberration phenotypes and genomic instability BMC Cancer 6 96 10.1186/1471-2407-6-96 16620391 10.1186/1471-2407-6-96
23. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 6797 747 752 10.1038/35021093 10963602 10.1038/35021093 1:CAS:528:DC%2BD3cXmt1CnsLw%3D
24. HM Horlings C Lai DS Nuyten H Halfwerk P Kristel E van Beers SA Joosse C Klijn PM Nederlof MJ Reinders LF Wessels MJ van de Vijver 2010 Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients Clin Cancer Res 16 2 651 663 10.1158/1078-0432.CCR-09-0709 20068109 10.1158/1078-0432.CCR-09-0709 1:CAS:528:DC%2BC3cXktF2qt7k%3D
25. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu T Hernandez-Boussard C Livasy D Cowan L Dressler LA Akslen J Ragaz AM Gown CB Gilks M van de Rijn CM Perou 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 16 5367 5374 10.1158/1078-0432.CCR-04-0220 15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D (Pubitemid 39100473)
26. Y Ge N Sneige MA Eltorky Z Wang E Lin Y Gong M Guo 2009 Immunohistochemical characterization of subtypes of male breast carcinoma Breast Cancer Res 11 3 R28 10.1186/bcr2258 19442295 10.1186/bcr2258
27. B Baldetorp PO Bendahl M Ferno O Stal 2003 Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines Cytometry A 56 1 1 7 10.1002/cyto.a.10083 14566933 10.1002/cyto.a.10083 (Pubitemid 37522500)
28. Chang H (2010) Howard Chang's lab homepage. http://changlab.stanford.edu/ protocols.html. Accessed 20 Oct 2010
29. G Jonsson J Staaf E Olsson M Heidenblad J Vallon-Christersson K Osoegawa P de Jong S Oredsson M Ringner M Hoglund A Borg 2007 High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization Genes Chromosomes Cancer 46 6 543 558 10.1002/gcc.20438 17334996 10.1002/gcc.20438 (Pubitemid 46649569)
30. J Staaf G Jonsson M Ringner J Vallon-Christersson 2007 Normalization of array-CGH data: influence of copy number imbalances BMC Genomics 8 382 10.1186/1471-2164-8-382 17953745 10.1186/1471-2164-8-382
31. ES Venkatraman AB Olshen 2007 A faster circular binary segmentation algorithm for the analysis of array CGH data Bioinformatics 23 6 657 663 10.1093/bioinformatics/btl646 17234643 10.1093/bioinformatics/btl646 1:CAS:528:DC%2BD2sXkt1Ghtrw%3D (Pubitemid 46554715)
32. C Marchio MB Lambros P Gugliotta LV Di Cantogno C Botta B Pasini DS Tan A Mackay K Fenwick N Tamber G Bussolati A Ashworth JS Reis-Filho A Sapino 2009 Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis J Pathol 219 1 16 24 10.1002/path.2574 19670217 10.1002/path.2574 1:CAS:528: DC%2BD1MXhtFGgs7%2FI
33. R Beroukhim G Getz L Nghiemphu J Barretina T Hsueh D Linhart I Vivanco JC Lee JH Huang S Alexander J Du T Kau RK Thomas K Shah H Soto S Perner J Prensner RM Debiasi F Demichelis C Hatton MA Rubin LA Garraway SF Nelson L Liau PS Mischel TF Cloughesy M Meyerson TA Golub ES Lander IK Mellinghoff WR Sellers 2007 Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma Proc Natl Acad Sci USA 104 50 20007 20012 10.1073/pnas.0710052104 18077431 10.1073/pnas.0710052104 1:CAS:528: DC%2BD1cXhs1WmtQ%3D%3D
34. J Staaf G Jonsson M Ringner J Vallon-Christersson D Grabau A Arason H Gunnarsson BA Agnarsson PO Malmstrom OT Johannsson N Loman RB Barkardottir A Borg 2010 High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer Breast Cancer Res 12 3 R25 10.1186/bcr2568 20459607 10.1186/bcr2568
35. The R Project for Statistical Computing. www.r-project.org
36. VG Tusher R Tibshirani G Chu 2001 Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 98 9 5116 5121 10.1073/pnas.091062498 11309499 10.1073/pnas.091062498 1:CAS:528: DC%2BD3MXjt1Ons7w%3D (Pubitemid 32397092)
37. AR Green C Burney CJ Granger EC Paish S El-Sheikh EA Rakha DG Powe RD Macmillan IO Ellis E Stylianou 2008 The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome Breast Cancer Res Treat 110 3 427 437 10.1007/s10549-007-9737-y 17902051 10.1007/s10549-007-9737-y 1:CAS:528:DC%2BD1cXosVOgt70%3D (Pubitemid 351962584)
38. B Zhang DV Faller S Wang 2009 HIC1 regulates tumor cell responses to endocrine therapies Mol Endocrinol 23 12 2075 2085 10.1210/me.2009-0231 19819984 10.1210/me.2009-0231 1:CAS:528:DC%2BD1MXhsFKlur3K
39. J Xu S Lv Y Qin F Shu Y Xu J Chen BE Xu X Sun J Wu 2007 TRB3 interacts with CtIP and is overexpressed in certain cancers Biochim Biophys Acta 1770 2 273 278 10.1016/j.bbagen.2006.09.025 17112672 1:CAS:528:DC%2BD2sXhvVWmsw%3D%3D (Pubitemid 46019808)
40. Akisik E, Yazici H, Dalay N (2010) ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer. Mol Biol Rep. doi: 10.1007/s11033-010-0113-3
41. F Andre B Job P Dessen A Tordai S Michiels C Liedtke C Richon K Yan B Wang G Vassal S Delaloge GN Hortobagyi WF Symmans V Lazar L Pusztai 2009 Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array Clin Cancer Res 15 2 441 451 10.1158/1078-0432.CCR-08-1791 19147748 10.1158/1078-0432.CCR-08-1791 1:CAS:528:DC%2BD1MXlvFeksA%3D%3D
42. K Rennstam M Ahlstedt-Soini B Baldetorp PO Bendahl A Borg R Karhu M Tanner M Tirkkonen J Isola 2003 Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization Cancer Res 63 24 8861 8868 14695203 1:CAS:528:DC%2BD3sXhtVSqtbrP (Pubitemid 38064066)
43. C Rudlowski HJ Schulten MM Golas B Sander R Barwing JE Palandt B Schlehe R Lindenfelser R Moll T Liersch V Schumpelick B Gunawan L Fuzesi 2006 Comparative genomic hybridization analysis on male breast cancer Int J Cancer 118 10 2455 2460 10.1002/ijc.21646 16353155 10.1002/ijc.21646 1:CAS:528:DC%2BD28XktlGiurs%3D
44. ZA Nahleh 2006 Hormonal therapy for male breast cancer: a different approach for a different disease Cancer Treat Rev 32 2 101 105 10.1016/j.ctrv.2005.12.007 16472925 10.1016/j.ctrv.2005.12.007 1:CAS:528:DC%2BD28XisFOqt7g%3D (Pubitemid 43362231)
45. M Tirkkonen T Kainu N Loman OT Johannsson H Olsson RB Barkardottir OP Kallioniemi A Borg 1999 Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer Genes Chromosomes Cancer 24 1 56 61 9892109 10.1002/(SICI)1098-2264(199901)24:1<56::AID-GCC8>3.0.CO;2-X 1:CAS:528:DyaK1cXotVShurs%3D (Pubitemid 28544463)
46. BA Howard BA Gusterson 2000 Human breast development J Mammary Gland Biol Neoplasia 5 2 119 137 11149569 10.1023/A:1026487120779 1:STN:280: DC%2BD3M7jvVegtg%3D%3D (Pubitemid 32045692)
47. J Russo LK Tay IH Russo 1982 Differentiation of the mammary gland and susceptibility to carcinogenesis Breast Cancer Res Treat 2 1 5 73 6216933 10.1007/BF01805718 1:CAS:528:DyaL38XlsVamtrk%3D (Pubitemid 12017450)
48. A Pich E Margaria L Chiusa R Ponti M Geuna 1996 DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma Hum Pathol 27 7 676 682 8698311 10.1016/S0046-8177(96)90397-4 1:STN:280:DyaK28zitVKgsA%3D%3D (Pubitemid 26240319)
49. CB Bagwell GM Clark F Spyratos A Chassevent PO Bendahl O Stal D Killander ML Jourdan S Romain B Hunsberger B Baldetorp 2001 Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens Cytometry 46 3 121 135 11449403 10.1002/cyto.1097 1:STN:280:DC%2BD3Mzpslerug%3D%3D (Pubitemid 32643094)
50. AE Pinto S Andre J Soares 1999 Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients J Clin Pathol 52 8 604 611 10645231 10.1136/jcp.52.8.604 1:STN:280:DC%2BD3c7gvFyhtA%3D%3D (Pubitemid 29371906)
51. YS Zhu 2005 Molecular basis of steroid action in the prostate Cellscience 1 4 27 55 10.1901/jaba.2005.1-27 16971966
52. JD McConnell CG Roehrborn OM Bautista GL Andriole Jr CM Dixon JW Kusek H Lepor KT McVary LM Nyberg Jr HS Clarke ED Crawford A Diokno JP Foley HE Foster SC Jacobs SA Kaplan KJ Kreder MM Lieber MS Lucia GJ Miller M Menon DF Milam JW Ramsdell NS Schenkman KM Slawin JA Smith Medical Therapy of Prostatic Symptoms Research Group 2003 The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 25 2387 2398 10.1056/NEJMoa030656 14681504 10.1056/NEJMoa030656 1:CAS:528:DC%2BD3sXpvFGqt7s%3D (Pubitemid 37542987)
53. MD Trifiro JK Parsons K Palazzi-Churas J Bergstrom C Lakin E Barrett-Connor 2009 Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men BJU Int 105 11 1554 1559 10.1111/j.1464-410X.2009.09090.x 20002438 10.1111/j.1464-410X.2009.09090.x
54. I Hedenfalk D Duggan Y Chen M Radmacher M Bittner R Simon P Meltzer B Gusterson M Esteller OP Kallioniemi B Wilfond A Borg J Trent 2001 Gene-expression profiles in hereditary breast cancer N Engl J Med 344 8 539 548 10.1056/NEJM200102223440801 11207349 10.1056/NEJM200102223440801 1:CAS:528:DC%2BD3MXhsFGks7o%3D (Pubitemid 32167867)